Alanazi, A.M.; Fadda, L.; Alhusaini, A.; Ahmad, R.; Hasan, I.H.; Mahmoud, A.M.
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats. Antioxidants 2020, 9, 159.
https://doi.org/10.3390/antiox9020159
AMA Style
Alanazi AM, Fadda L, Alhusaini A, Ahmad R, Hasan IH, Mahmoud AM.
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats. Antioxidants. 2020; 9(2):159.
https://doi.org/10.3390/antiox9020159
Chicago/Turabian Style
Alanazi, Abeer M., Laila Fadda, Ahlam Alhusaini, Rehab Ahmad, Iman H. Hasan, and Ayman M. Mahmoud.
2020. "Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats" Antioxidants 9, no. 2: 159.
https://doi.org/10.3390/antiox9020159
APA Style
Alanazi, A. M., Fadda, L., Alhusaini, A., Ahmad, R., Hasan, I. H., & Mahmoud, A. M.
(2020). Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats. Antioxidants, 9(2), 159.
https://doi.org/10.3390/antiox9020159